These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33097818)

  • 21. CCL3 and MMP-9 are induced by TL1A during death receptor 3 (TNFRSF25)-dependent osteoclast function and systemic bone loss.
    Collins FL; Williams JO; Bloom AC; Singh RK; Jordan L; Stone MD; McCabe LR; Wang ECY; Williams AS
    Bone; 2017 Apr; 97():94-104. PubMed ID: 28062298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.
    Buttó LF; Jia LG; Arseneau KO; Tamagawa H; Rodriguez-Palacios A; Li Z; De Salvo C; Pizarro TT; Bamias G; Cominelli F
    Inflamm Bowel Dis; 2019 Jan; 25(1):14-26. PubMed ID: 30295722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect and Mechanism of TL1A Expression on Epithelial-Mesenchymal Transition during Chronic Colitis-Related Intestinal Fibrosis.
    Wenxiu J; Mingyue Y; Fei H; Yuxin L; Mengyao W; Chenyang L; Jia S; Hong Z; Shih DQ; Targan SR; Xiaolan Z
    Mediators Inflamm; 2021; 2021():5927064. PubMed ID: 34257516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
    Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F
    J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.
    Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT
    Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Directed evolution of a soluble human DR3 receptor for the inhibition of TL1A induced cytokine secretion.
    Levin I; Zaretsky M; Aharoni A
    PLoS One; 2017; 12(3):e0173460. PubMed ID: 28278297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of TL1A and DR3 in autoimmune and inflammatory diseases.
    Aiba Y; Nakamura M
    Mediators Inflamm; 2013; 2013():258164. PubMed ID: 24453414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases.
    Siakavellas SI; Sfikakis PP; Bamias G
    Semin Arthritis Rheum; 2015 Aug; 45(1):1-8. PubMed ID: 25887448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
    Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
    Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.
    Meylan F; Song YJ; Fuss I; Villarreal S; Kahle E; Malm IJ; Acharya K; Ramos HL; Lo L; Mentink-Kane MM; Wynn TA; Migone TS; Strober W; Siegel RM
    Mucosal Immunol; 2011 Mar; 4(2):172-85. PubMed ID: 20980995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor-like cytokine 1A plays a role in inflammatory bowel disease pathogenesis.
    Meng F; Jiang X; Wang X; Zheng Q; Wang XN; Mei C; Yan S; He Y; Xue J; Zhang X; Fu W; You Y; Zhai J; Wang Y; Sun X
    Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2120771120. PubMed ID: 37579137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia.
    Taraban VY; Slebioda TJ; Willoughby JE; Buchan SL; James S; Sheth B; Smyth NR; Thomas GJ; Wang EC; Al-Shamkhani A
    Mucosal Immunol; 2011 Mar; 4(2):186-96. PubMed ID: 20962771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TL1A/DR3 Axis, A Key Target of TNF-a, Augments the Epithelial-Mesenchymal Transformation of Epithelial Cells in OVA-Induced Asthma.
    Zhang D; Yang H; Dong XL; Zhang JT; Liu XF; Pan Y; Zhang J; Xu JW; Wang ZH; Cui WJ; Dong L
    Front Immunol; 2022; 13():854995. PubMed ID: 35359966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of TL1A and DR3 in induction of ischaemia and inflammation in urinary bladder dysfunction in the elderly.
    Wang W; Zhang N; Zhu XH; He ZS; Wahafu W; Xu ZQ; Yang Y
    Mol Med Rep; 2012 Aug; 6(2):434-8. PubMed ID: 22641456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progranulin-derived Atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity.
    Liu C; Li XX; Gao W; Liu W; Liu DS
    PLoS One; 2014; 9(3):e92743. PubMed ID: 24651300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel role for TL1A/DR3 deficiency in acute respiratory distress syndrome that exacerbates alveolar epithelial disruption.
    Zhang D; Zhang J; Zhang J; Ji X; Qi Q; Xu J; Pan Y; Liu X; Sun F; Zeng R; Dong L
    Respir Res; 2023 Jul; 24(1):182. PubMed ID: 37434162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TL1A both promotes and protects from renal inflammation and injury.
    Al-Lamki RS; Wang J; Tolkovsky AM; Bradley JA; Griffin JL; Thiru S; Wang EC; Bolton E; Min W; Moore P; Pober JS; Bradley JR
    J Am Soc Nephrol; 2008 May; 19(5):953-60. PubMed ID: 18287561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introductory words about TL1A/DR3.
    Targan SR
    Adv Exp Med Biol; 2011; 691():271-4. PubMed ID: 21153330
    [No Abstract]   [Full Text] [Related]  

  • 39. Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis.
    Li Z; Buttó LF; Buela KA; Jia LG; Lam M; Ward JD; Pizarro TT; Cominelli F
    Front Immunol; 2018; 9():362. PubMed ID: 29545797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oestrogen-deficiency induces bone loss by modulating CD14
    Collins FL; Stone MD; Turton J; McCabe LR; Wang ECY; Williams AS
    BMC Musculoskelet Disord; 2019 Jul; 20(1):326. PubMed ID: 31299941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.